Novanta Inc

Novanta Inc. is a U.S.-based industrial technology company that supplies proprietary components and subsystems to original equipment manufacturers in medical and advanced industrial markets. Its portfolio includes motion control, laser beam delivery, machine vision, video processing, sensing, identification, and medical device technologies sold globally through direct sales and distribution channels.

15,9 %

44,4 %

5,5 %

+3,3 %

3.69

2.80

— Novanta Inc
%
Medical Solutions53% Medical-grade technologies and subsystems used in surgical, diagnostic, and life science equipment.
Advanced Industrial Solutions47% Precision technologies and components used in automation, manufacturing, and industrial OEM systems.

Novanta sells primarily to OEMs that integrate its technologies into medical devices and industrial equipment...

  • Medical OEMsprimary

    Buy medical-grade subsystems and devices for surgical, diagnostic, and life science platforms; they need regulatory-ready, high-reliability components.

  • Advanced industrial OEMsprimary

    Buy precision technologies for automation, robotics, manufacturing, and inspection systems where performance and integration matter.

  • Life science and healthcare providers via OEM channelssecondary

    Indirect end demand for equipment used in hospitals, labs, and healthcare networks.

  • Distributors and resellerssecondary

    Purchase selected products to extend local market reach and support smaller accounts.

Novanta sells products globally and maintains service and application centers in the United States, Europe, and Asia...

  • Global sales footprint across the United States, Europe, and Asia
  • Service and application centers support customer integration worldwide
  • About 47% of revenue comes from customers outside the U.S.
  • International exposure increases FX, logistics, and collection risk
  • Manufacturing operations are certified across quality and safety standards

Novanta’s strategy centers on proprietary technology solutions for long-life OEM platforms in medical and advanced...

01
Deepen penetration in medical OEM platformsmedium-term

Medical programs tend to have long design cycles and sticky customer relationships.

02
Strengthen proprietary technology breadthmedium-term

Broader technology coverage improves cross-selling and customer retention.

03
Support global OEM customers with local technical presenceshort-term

Application support and service proximity are key differentiators in design-in markets.

Novanta faces demand cyclicality tied to medical capital spending, industrial production cycles, and OEM product launch...

high

Customer concentration

A small number of OEMs can represent a meaningful share of revenue, increasing dependence on their launch and purchasing decisions.

Scope
Two OEM customers represented approximately 12% and 11% of 2025 revenue.
Materiality
high
high

Cyclical end-market demand

Medical and advanced industrial sales depend on customer capital budgets, procedure volumes, and manufacturing investment cycles.

Scope
Medical and advanced industrial end markets
Materiality
high
high

Cybersecurity and IT disruption

Operational systems connect with customers and suppliers, so outages or breaches can interrupt revenue and create liability.

Scope
Customer and supplier systems
Materiality
high
medium

Trade policy and inflation

Tariffs, retaliatory measures, and inflation can increase input costs and pressure pricing.

Scope
Global manufacturing and sourcing
Materiality
high
medium

Foreign exchange and international operations

A large share of revenue is generated outside the U.S., creating translation and transaction exposure.

Scope
Approximately 47% of revenue from outside the U.S.
Materiality
medium
Revenue recognition timing
Affects quarterly comparability and cutoff judgments
Service plans and warranties
Creates deferred revenue and timing differences
Goodwill and intangible impairment
Can create non-cash charges if performance weakens
Inventory valuation
May affect gross margin and working capital
Income tax estimates
Can cause volatility in effective tax rate

: 29.4.2026